StockData
Verrica Pharmaceuticals Inc. logo

Verrica Pharmaceuticals Inc. (VRCA) stock

VRCANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$2.85−0.29 (-9.08%)

Close on Nov 18, 2026Market cap $49.05MP/E –Yield –

Verrica Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Verrica Pharmaceuticals

Verrica Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Verrica Pharmaceuticals figures

See a number that looks wrong?